The global pain management devices market is on a strong upward trajectory, projected to grow from USD 5,277.30 million in 2024 to USD 9,350.72 million by 2032, expanding at a CAGR of 7.53% between 2025 and 2032. This growth is fueled by the rising prevalence of chronic pain, an aging global population, frequent product launches, and a decisive shift away from opioid-based therapies toward safer, non-pharmacological alternatives.
Pain Management Industry Overview
The broader pain management industry is being reshaped by the opioid crisis, which has pushed clinicians and patients toward device-based solutions that avoid the addiction risks and side effects associated with oral medications. Devices work by stimulating the body’s natural pain-relieving mechanisms or by blocking pain signals before they reach the brain, making them attractive for musculoskeletal pain, cancer pain, and neuropathic pain. Neurostimulation devices, particularly spinal cord stimulators, dominate the segment, accounting for roughly 55% of the market, with spinal cord stimulators alone representing more than 45% share within that category due to their established role in treating chronic and refractory pain.
US Pain Management Devices Market
North America, led by the United States, commands close to 45% of global revenue, supported by a high burden of chronic pain, favorable reimbursement structures, and frequent FDA approvals. The US pain management devices market benefits from striking epidemiological data: in 2021, an estimated 51.6 million U.S. adults lived with chronic pain, and 17.1 million experienced high-impact chronic pain that limits daily life. Recent regulatory milestones include Medtronic’s Inceptiv closed-loop spinal cord stimulator, Abbott’s Eterna SCS system, and Nevro’s AI-driven HFX AdaptivAI platform, all of which illustrate how innovation and approvals continue to drive adoption in this region.
Infusion Pain Management Devices Market
Beyond neurostimulation, the infusion pain management devices market covers intrathecal and external analgesic infusion pumps that deliver medication directly and continuously to targeted sites, offering an alternative for patients with severe or treatment-resistant pain. This segment complements ablation devices, such as radiofrequency and cryoablation systems, rounding out a diverse device-type landscape that spans electrical stimulation, infusion, and ablation technologies.
Chronic Post-Amputation Pain Medical Devices Market
A notable niche within this space is the chronic post-amputation pain medical devices market, where companies like Neuros Medical are developing targeted nerve stimulation therapies, such as the Altius system, specifically for post-amputation and neuropathic pain. This reflects a broader industry trend of startups securing significant funding to address highly specific, underserved pain conditions with precision neuromodulation technologies.
Pain Monitoring Device Market
Complementing therapeutic devices, the pain monitoring device market is gaining relevance as artificial intelligence and digital health integration allow for more objective, data-driven assessment of pain. AI-enabled tools can analyze facial expressions, body movement, and wearable sensor data to quantify pain levels, supporting more personalized and timely interventions, especially in home care settings where remote monitoring is increasingly valued.
Pain Management Software Market
Digital platforms are also becoming central to modern care pathways. The pain management software market is expanding as companies integrate neuromodulation devices with digital applications; for instance, partnerships between neurostimulation device makers and digital care platforms are creating holistic offerings that combine hardware with software-based coaching, remote programming, and virtual clinic capabilities for ongoing patient management.
Central Pain Syndrome Management Market
Neurological pain conditions are a major growth driver as well. The central pain syndrome management market is supported by the sheer scale of neurological disorders worldwide, which affect an estimated 3.4 billion people globally. Migraines and tension-type headaches alone account for billions of cases, and neurostimulation systems targeting specific nerve pathways have proven effective in interrupting these pain signals.
Which Companies Are Recognised for Building a Superior Portfolio of Pain Relief Brands?
Leading multinational corporations dominate this competitive landscape. Medtronic, Boston Scientific, and Abbott Laboratories are widely recognized for their strong R&D capabilities, clinical evidence, and global distribution networks, particularly in implantable neurostimulation devices. Other prominent players include Baxter International, Nevro Corp., Avanos Medical, Omron Corporation, Zynex Inc., B. Braun SE, and ICU Medical. Smaller innovators such as Nevro, Neuros Medical, and Presidio Medical are also gaining recognition for disruptive closed-loop and ultra-low-frequency stimulation technologies.
Pain Management Market Outlook
Overall, the wider pain management market is set for sustained expansion through 2032, driven by demographic shifts, chronic disease burden, and continuous technological innovation, even as high device costs and regulatory complexity remain notable restraints on faster adoption.
Latest Reports Offered by Delveinsight
echocardiography devices market | endometrial cancer market | fabry disease market | friedreich’s ataxia market | giant papillary conjunctivitis market | gm2 gangliosidosis market | goitre market | gpcr-targeting therapies market | her2-negative breast cancer market | hr+/her- breast cancer market | hyperkalemia market | hypertrophic scar market | insulin glargine biosimilar | intracranial hemorrhage market | invasive pneumococcal disease market | knee osteoarthritis market | lsd1 inhibitor market | ly3454738 drug insight | medical sterilization equipment market | meniscus tear market | methicillin-resistant staphylococcus aureus mrsa infection market | mucopolysaccharidosis i market | myc proto oncogene protein market | myopia progression market share | narcolepsy market | neuromyelitis optica market | neurovascular catheters market
About Delveinsight
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk